United States Clinical Nutrition Market - By Product Type: Enteral Nutrition (EN), Parenteral Nutrition (PN), Oral Nutritional Supplements; By End User: Hospitals & Specialty Clinics, Home Health Agencies, Long-Term Care Facilities.
Market Overview
The U.S. clinical nutrition market is experiencing sustained growth driven by an aging population, a high burden of chronic disease, and an increasing demand for integrated hospital and home-based nutrition therapy. Clinical nutrition is now a critical element of treatment plans for oncology, diabetes, cardiovascular, and gastrointestinal disorders. With established reimbursement structures under Medicare, Medicaid, and commercial payers, as well as the rising adoption of digital health technologies, the U.S. is a global leader in clinical nutrition innovation.
Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
13.9 |
Includes inpatient, outpatient, and homecare-based enteral, parenteral, and oral nutrition |
|
2024 |
20.3 |
CAGR 7.9% (2019–2024); fueled by ICU protocols and chronic disease prevalence |
|
2031 |
32.1 |
CAGR 6.9% (2024–2031); personalized and digital nutrition platforms gain traction |
Market Drivers
Market Challenges
Competitive Landscape
|
Company |
2024 Share |
Market Strengths |
Notable Developments |
|
Abbott Nutrition |
25% |
Glucerna, Ensure, hospital-adopted lines |
Launched AI diet prescription platform for cancer patients (Q2 2025) |
|
Nestlé Health Science |
20% |
Peptamen, Boost, GI and pediatric nutrition |
Partnered with U.S. oncology networks for tube feed protocols (2024) |
|
Danone Nutricia |
14% |
Adult recovery and renal nutrition |
Expanded plant-based formulations for metabolic patients (2024) |
|
Fresenius Kabi |
12% |
Parenteral nutrition and compounding kits |
Acquired home infusion service provider (Q3 2024) |
|
Others (Baxter, B. Braun, regional players) |
29% |
Specialty products and hospital supply contracts |
Focused on pediatric and home IV segments |
Market Segmentation
By Product Type:
By End User:
Regional Dynamics
Recent Developments
Strategic Outlook
The U.S. clinical nutrition market is poised to evolve through EHR-integrated therapy planning, payer-driven outcomes reporting, and home-based nutrition automation. Digital dietitians, smart pumps, and remote monitoring will reshape adherence and personalization by 2031.
Methodology
Clearview Market Insights conducted 104 interviews with U.S.-based clinical dietitians, hospital procurement leaders, and payer policy analysts. Forecasting relied on CMS reimbursement datasets, home infusion registry data, and AI adoption metrics.
Need help?
Chat with our team in a minute.